Anthonie J Wekken
9PUBLICATIONS
89CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano
|Jul 25, 2025
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.Fenna de Vries, Eric J F Franssen, Arthur A J Smit
|May 28, 2025
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer.Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen
|Apr 14, 2025
Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients.Weiting Li, Fenneke Zwierenga, Katarina D Andini
|May 22, 2024
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib.Vincent D de Jager, Jos A Stigt, Maarten Niemantsverdriet
Pageof 2
Frequent Collaborators
2 joint publications
Benjamin Besse
2 joint publications
Sai-Hong Ignatius Ou
2 joint publications
Shirish M Gadgeel
2 joint publications
Luis Paz-Ares Rodriguez
2 joint publications
Adrianus Johannes de Langen
1 joint publications
Alexander Drilon
1 joint publications
Joshua C Horan
1 joint publications
Anupong Tangpeerachaikul
1 joint publications
Ron H J Mathijssen
1 joint publications
Linh Nguyen-Phuong